The term 'carcinoid syndrome' is used to describe the hormonal manifestations of carcinoid tumours and occurs secondary to the secretion of serotonin, tachykinins, bradykinins and prostaglandins. This evidence concerns the gene KNG1 and carcinoid syndrome.